• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconKite Pharma

Kite Pharma

Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
HealthWhy Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By Sy MukherjeeJanuary 22, 2018
Iris Network Student
HealthGene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By Sy MukherjeeNovember 16, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
HealthThe FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By Sy MukherjeeOctober 19, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
HealthGilead’s Deal to Buy Kite Pharma Is a Game-Changer
By Sy MukherjeeAugust 28, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Fall While Dow Poised To End Streak
HealthKite Pharma’s Shares Soared Today Thanks to Its Revolutionary Blood Cancer Drug
By Sy MukherjeeFebruary 28, 2017
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
HealthWhy Shares of Next-Gen Cancer Biotech Juno Rallied Today
By Sy MukherjeeJuly 13, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthThese Are the Most Promising Experimental Cancer Drugs
By Sy MukherjeeJune 9, 2016
1
  • 1
1
Most Popular
Innovation
Google CEO Sundar Pichai says we’re just a decade away from a new normal of extraterrestrial data centersplaceholder alt text
By Fortune EditorsApril 3, 2026
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Fortune EditorsApril 2, 2026
Magazine
The Walmart billionaires next door: Quiet backlash is brewing against the heirs who remade the retailer’s hometownplaceholder alt text
By Fortune EditorsApril 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.